Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2026
BioAdaptives launches XcellaraHeart cardiovascular supplement
BioAdaptives, Inc. announced the commercial launch and pre-order availability of XcellaraHeart, a pharmaceutical-grade daily cardiovascular supplement and flagship product of its new Xcellara cellular wellness platform. The product is priced at $159.95 per bottle with a 30-day money-back guarantee and free U.S. shipping, with the first commercial batch scheduled to ship on August 26, 2026.